EKF Diagnostics Presents Latest Diabetes Care Analyzers
By LabMedica International staff writers Posted on 31 Jan 2019 |

Image: The Lactate Scout 4 analyzer for athletes (Photo courtesy of EKF Diagnostics).
EKF Diagnostics (Cardiff, Wales, UK) presented its latest diabetes care analyzers at MedLab Middle East, a leading laboratory and flagship exhibition and conference spanning across the Middle East, Asia and West Europe. MedLab Middle East 2019 provided an international platform for laboratory management and medicine to exhibit their products ranging from ayurvedic & herbal to medical & pharmaceutical essentials in medical research & development & scientific instruments. The Conference provided education, best practices and the chance to learn, meet and network with leading laboratorians from across the globe.
At MedLab Middle East, EKF Diagnostics displayed DiaSpect Tm, the world’s fastest hemoglobin analyzer that delivers laboratory quality results in just about one second of the microcuvette being placed into the analyzer. The hemoglobin analyzer is palm-sized, making it easily transportable, and ideal for use in any screening setting even in challenging climatic environments. EKF Diagnostics also exhibited the Quo-Lab HbA1c desktop point-of-care analyzer for measuring glycated hemoglobin (HbA1c). The semi-automated analyzer has been designed specifically to meet the needs of diabetes clinics and laboratories in settings that demand low cost of operation and ease of use.
Also on display at the event was EKF Diagnostics’ Quo-Test HbA1c system, a fully automated HbA1c analyzer that uses patented boronate affinity fluorescence quenching technology to measure HbA1c from a 4-μl sample taken from a finger prick or venous whole blood. It has been designed for easy and reliable HbA1c measurement for the monitoring and management of diabetes in a point-of-care setting such as diabetes clinics and doctors’ surgeries. EKF Diagnostics’ also exhibited Hemo Control, its point-of-care hemoglobin analyzer designed to provide quantitative, lab quality hemoglobin results from 25 seconds. Hemo Control uses the most established photometric azide methemoglobin method, ensuring reliable results with a high precision (CV <2%).
Among the latest products displayed by EKF Diagnostics at MedLab Middle East was its new Lactate Scout 4 lactate analyzer for athletes. Lactate Scout 4 is used by sports medicine and sport professionals for the easy and reliable measurement of lactate while training on the track, working out in the gym or analyzing their performance in the laboratory. It has been ergonomically designed to be effectively used in the field as a training companion for coaches and athletes to determine optimum training programs, define training zones, and avoid inefficient training exercises. The hand-held lactate analyzer requires just 0.2 µl of capillary blood and returns results in 10 seconds. Up to 500 results can be stored on the Lactate Scout 4, which also features easy connection to heart rate monitors, stopwatch function to aid performance measurement, integrated step test function and Bluetooth connectivity.
At MedLab Middle East, EKF Diagnostics displayed DiaSpect Tm, the world’s fastest hemoglobin analyzer that delivers laboratory quality results in just about one second of the microcuvette being placed into the analyzer. The hemoglobin analyzer is palm-sized, making it easily transportable, and ideal for use in any screening setting even in challenging climatic environments. EKF Diagnostics also exhibited the Quo-Lab HbA1c desktop point-of-care analyzer for measuring glycated hemoglobin (HbA1c). The semi-automated analyzer has been designed specifically to meet the needs of diabetes clinics and laboratories in settings that demand low cost of operation and ease of use.
Also on display at the event was EKF Diagnostics’ Quo-Test HbA1c system, a fully automated HbA1c analyzer that uses patented boronate affinity fluorescence quenching technology to measure HbA1c from a 4-μl sample taken from a finger prick or venous whole blood. It has been designed for easy and reliable HbA1c measurement for the monitoring and management of diabetes in a point-of-care setting such as diabetes clinics and doctors’ surgeries. EKF Diagnostics’ also exhibited Hemo Control, its point-of-care hemoglobin analyzer designed to provide quantitative, lab quality hemoglobin results from 25 seconds. Hemo Control uses the most established photometric azide methemoglobin method, ensuring reliable results with a high precision (CV <2%).
Among the latest products displayed by EKF Diagnostics at MedLab Middle East was its new Lactate Scout 4 lactate analyzer for athletes. Lactate Scout 4 is used by sports medicine and sport professionals for the easy and reliable measurement of lactate while training on the track, working out in the gym or analyzing their performance in the laboratory. It has been ergonomically designed to be effectively used in the field as a training companion for coaches and athletes to determine optimum training programs, define training zones, and avoid inefficient training exercises. The hand-held lactate analyzer requires just 0.2 µl of capillary blood and returns results in 10 seconds. Up to 500 results can be stored on the Lactate Scout 4, which also features easy connection to heart rate monitors, stopwatch function to aid performance measurement, integrated step test function and Bluetooth connectivity.
Latest MEDLAB 2019 News
- ERBA Group Launches New Hematology Analyzers at MEDLAB 2019
- Telstar Promotes Latest Generation of Freeze Dryers in Dubai
- Siemens Healthineers Showcases In-Vitro Diagnostics Products at MedLab 2019
- Randox Promotes Evidence MultiSTAT Automated Benchtop Immunoassay Analyzer
- Mindray Displays New Generation Benchtop Cellular Analysis Line
- HORIBA Medical Shows Latest Yumizen G Range at Lab Trade Show
- Greiner Bio-One Displays Range of Safety Products at MedLab
- BioSystems Highlights New iFOB Integral System at MedLab 2019
- Beckman Coulter Exhibits New Hematology Analyzer in Middle East
- Agappe Diagnostics Displays Analyzers and Solutions at Middle East Congress
- Abbott Highlights Point of Care Management Solutions
Channels
Clinical Chemistry
view channel
New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read moreMolecular Diagnostics
view channel
RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia
A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more
New Technique for Measuring Acidic Glycan in Blood Simplifies Schizophrenia Diagnosis
Polysialic acid is a unique acidic glycan predominantly found in brain regions associated with memory and emotion, but it is also present in the bloodstream. Research has shown that blood levels of polysialic... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
Blood Test Detects Organ Rejection in Heart Transplant Patients
Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer
Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more
Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance
Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read moreMicrobiology
view channel
Viral Load Tests Can Help Predict Mpox Severity
Mpox is a viral infection that causes flu-like symptoms and a characteristic rash, which evolves significantly over time and varies between patients. The disease spreads mainly through direct contact with... Read more
Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. It significantly heightens the risk of... Read morePathology
view channel
AI Performs Virtual Tissue Staining at Super-Resolution
Conventional histopathology, essential for diagnosing various diseases, typically involves chemically staining tissue samples to reveal cellular structures under a microscope. This process, known as “histochemical... Read more
AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis
Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response
Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy
Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read moreTechnology
view channel
Inexpensive DNA Coated Electrode Paves Way for Disposable Diagnostics
Many people around the world still lack access to affordable, easy-to-use diagnostics for diseases like cancer, HIV, and influenza. Conventional sensors, while accurate, often rely on expensive equipment... Read more
New Miniature Device to Transform Testing of Blood Cancer Treatments
Chimeric antigen receptor (CAR) T cell therapy has emerged as a groundbreaking treatment for blood cancers like leukemia, offering hope to patients when other treatments fail. However, despite its promise,... Read moreIndustry
view channel
Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
Lunit (Seoul, South Korea) and Microsoft (Redmond, WA, USA) have entered into a collaboration to accelerate the delivery of artificial intelligence (AI)-powered healthcare solutions. In conjunction with... Read more